Rheumatoid Arthritis Recruiting Phase 4 Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03737708A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)Treatment
NCT02374021Treatments Against RA and Effect on FDG-PET/CTTreatment
NCT03915964A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisTreatment
NCT03100253Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGationTreatment
NCT03505008Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanTreatment
NCT01602302Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid ArthritisTreatment
NCT01793519Stopping TNF Alpha Inhibitors in Rheumatoid ArthritisTreatment
NCT02242474Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid ArthritisTreatment
NCT02035800Bone Resorption, Osteoclastogenesis and AdalimumabBasic Science